EP3624730A4 - Compositions de biopolymères, échafaudages et dispositifs - Google Patents

Compositions de biopolymères, échafaudages et dispositifs Download PDF

Info

Publication number
EP3624730A4
EP3624730A4 EP18802108.3A EP18802108A EP3624730A4 EP 3624730 A4 EP3624730 A4 EP 3624730A4 EP 18802108 A EP18802108 A EP 18802108A EP 3624730 A4 EP3624730 A4 EP 3624730A4
Authority
EP
European Patent Office
Prior art keywords
scaffoldings
devices
biopolymer compositions
biopolymer
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18802108.3A
Other languages
German (de)
English (en)
Other versions
EP3624730A2 (fr
Inventor
Michael Francis
Nathan KEMPER
Hilary WRIGGERS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Embody Inc
Original Assignee
Embody Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Embody Inc filed Critical Embody Inc
Publication of EP3624730A2 publication Critical patent/EP3624730A2/fr
Publication of EP3624730A4 publication Critical patent/EP3624730A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/386—Ligaments, tendons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Textile Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP18802108.3A 2017-05-16 2018-05-15 Compositions de biopolymères, échafaudages et dispositifs Pending EP3624730A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762603026P 2017-05-16 2017-05-16
PCT/US2018/000119 WO2018212792A2 (fr) 2017-05-16 2018-05-15 Compositions de biopolymères, échafaudages et dispositifs

Publications (2)

Publication Number Publication Date
EP3624730A2 EP3624730A2 (fr) 2020-03-25
EP3624730A4 true EP3624730A4 (fr) 2021-04-14

Family

ID=64274548

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18802108.3A Pending EP3624730A4 (fr) 2017-05-16 2018-05-15 Compositions de biopolymères, échafaudages et dispositifs

Country Status (6)

Country Link
US (6) US10617787B2 (fr)
EP (1) EP3624730A4 (fr)
JP (3) JP2020520389A (fr)
AU (1) AU2018268713B2 (fr)
CA (1) CA3063847A1 (fr)
WO (1) WO2018212792A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11484401B2 (en) 2016-02-01 2022-11-01 Medos International Sarl Tissue augmentation scaffolds for use in soft tissue fixation repair
US20170273680A1 (en) 2016-02-01 2017-09-28 DePuy Synthes Products, Inc. Tissue augmentation tacks for use with soft tissue fixation repair systems and methods
US11357495B2 (en) 2016-02-01 2022-06-14 Medos International Sarl Tissue augmentation scaffolds for use with soft tissue fixation repair systems and methods
EP3624730A4 (fr) 2017-05-16 2021-04-14 Embody Inc. Compositions de biopolymères, échafaudages et dispositifs
CA3079958A1 (fr) 2017-10-24 2019-05-02 Embody Inc. Implants d'echafaudage de biopolymere et leurs methodes de production
WO2020160491A1 (fr) * 2019-02-01 2020-08-06 Embody, Inc. Extrusion microfluidique
CN110237304A (zh) * 2019-06-26 2019-09-17 上海市第六人民医院 一种多级结构支架及其制备方法
TWI777347B (zh) * 2020-12-31 2022-09-11 財團法人工業技術研究院 非纖維形式薄膜與細胞層片
NL2027479B1 (en) * 2021-02-02 2022-09-05 Medskin Solutions Dr Suwelack Ag Porous osteoinductive composites
CN113026199A (zh) * 2021-03-11 2021-06-25 北京化工大学 一种成分梯度化肌腱防粘连纤维膜及其制备方法
WO2023137481A2 (fr) 2022-01-17 2023-07-20 Embody, Inc. Implants comprimés pour réparation de tissu mou
CN114432501A (zh) * 2022-01-30 2022-05-06 上海松力生物技术有限公司 一种肩袖补片及其制备方法
CN117883216B (zh) * 2024-01-19 2024-08-09 常州集硕医疗器械有限公司 一种生物可吸收肩袖补片及其制备方法
US20250281671A1 (en) 2024-03-05 2025-09-11 Ocean Orthopedics, Inc. Expandable member and patch system for augmenting tissue

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010040129A2 (fr) * 2008-10-03 2010-04-08 Trustees Of Tufts College Echafaudages pour ingénierie tissulaire et médecine régénératrice
WO2014160019A1 (fr) * 2013-03-14 2014-10-02 Lifenet Health Fibre alignée et son procédé d'utilisation
WO2019084209A1 (fr) * 2017-10-24 2019-05-02 Embody Llc Implants d'échafaudage de biopolymère et leurs méthodes de production

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171273A (en) 1989-01-13 1992-12-15 University Of Medicine And Dentistry Of New Jersey Synthetic collagen orthopaedic structures such as grafts, tendons and other structures
GB2311027B (en) * 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
DE69732721T2 (de) 1996-12-03 2006-05-18 Osteobiologics, Inc., San Antonio Biologisch abbaubare kunstoff-folien
WO1998030252A1 (fr) 1997-01-09 1998-07-16 Cohesion Technologies, Inc. Procedes et appareils de fabrication de dispositifs gonflants uniformement formes a partir de materiaux polymeres
JP2002502822A (ja) 1998-02-10 2002-01-29 オレゴン ヘルス サイエンシーズ ユニバーシティー 骨芽細胞の前駆細胞による骨欠損の治療
US20020090725A1 (en) 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US7615373B2 (en) 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
ATE428768T1 (de) 1999-09-28 2009-05-15 Organogenesis Inc Biotechnische kollagenfibrillen
KR20020063020A (ko) 2001-01-26 2002-08-01 한국과학기술연구원 미세 섬유상 고분자웹의 제조 방법
WO2003004254A1 (fr) 2001-07-03 2003-01-16 The Regents Of The University Of California Matrices de biopolymeres microfabriquees et methode d'elaboration correspondante
US6855167B2 (en) 2001-12-05 2005-02-15 Osteotech, Inc. Spinal intervertebral implant, interconnections for such implant and processes for making
CA2493083C (fr) 2002-07-16 2012-11-06 Bio Syntech Canada Inc. Composition pour solutions de chitosane cytocompatibles, injectables et auto-gelifiantes destinees a l'encapsulation et a l'administration de cellules vivantes ou de facteurs biologiquement actifs
US7862831B2 (en) 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US20070225631A1 (en) 2002-10-04 2007-09-27 Bowlin Gary L Sealants for Skin and Other Tissues
US8197837B2 (en) 2003-03-07 2012-06-12 Depuy Mitek, Inc. Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
CA2528134C (fr) 2003-06-04 2015-05-12 University Of South Carolina Support tissulaire dote de fibrilles alignees, appareil et procede pour sa production, tissu artificiel et ses procedes d'utilisation
CN1287870C (zh) 2003-09-17 2006-12-06 启东致远生物科技有限公司 阴茎增长植入物
JP4009911B2 (ja) 2003-10-17 2007-11-21 亮平 深江 ゼラチン繊維の製造方法
WO2005065079A2 (fr) 2003-11-10 2005-07-21 Angiotech International Ag Implants medicaux et agents inducteurs de fibrose
EP1604693A1 (fr) 2004-06-09 2005-12-14 Scil Technology GmbH Support formé in situ, son procédé de préparation et son utilisation
JP5042025B2 (ja) * 2004-09-29 2012-10-03 ナショナル ユニヴァーシティー オブ シンガポール 複合物、複合物の製造方法、およびその使用方法
US20060154063A1 (en) 2004-12-15 2006-07-13 Kazutoshi Fujihara Nanofiber construct and method of preparing thereof
BRPI0608186A2 (pt) 2005-02-18 2011-01-04 Synthasome Inc estrutura sintética para reparo de tecidos moles
JP4975013B2 (ja) 2005-03-11 2012-07-11 ウエイク・フオレスト・ユニバーシテイ・ヘルス・サイエンシズ 組織が工作された心臓弁の製造
JP5232636B2 (ja) 2005-03-11 2013-07-10 ウエイク・フオレスト・ユニバーシテイ・ヘルス・サイエンシズ 組織の工作された血管
US20060204539A1 (en) 2005-03-11 2006-09-14 Anthony Atala Electrospun cell matrices
US8048446B2 (en) 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
DK2347775T3 (da) 2005-12-13 2020-07-13 Harvard College Skabeloner til celletransplantation
WO2007090102A2 (fr) 2006-01-27 2007-08-09 The Regents Of The University Of California squelettes biomimetiques
US8585753B2 (en) 2006-03-04 2013-11-19 John James Scanlon Fibrillated biodegradable prosthesis
WO2007109304A2 (fr) 2006-03-20 2007-09-27 University Of Florida Research Foundation, Inc. Nanoparticules de céramique et procédés permettant la formation de nanoparticules de céramique à partir de nanofibres électrofilées
KR101462431B1 (ko) * 2006-08-15 2014-11-17 에코신테틱스 리미티드 바이오폴리머 나노입자를 생산하기 위한 공정
US20100179659A1 (en) 2006-09-27 2010-07-15 Wan-Ju Li Cell-nanofiber composite and cell-nanofiber-hydrogel composite amalgam based engineered intervertebral disc
WO2008097901A1 (fr) 2007-02-02 2008-08-14 Tornier, Inc. Système et procédé pour réparer les tendons et les ligaments
US8753391B2 (en) 2007-02-12 2014-06-17 The Trustees Of Columbia University In The City Of New York Fully synthetic implantable multi-phased scaffold
WO2008100589A1 (fr) 2007-02-14 2008-08-21 Synthasome, Inc. Structure synthétique pour réparation de partie molle
EP2148887B1 (fr) 2007-04-19 2014-04-30 Fibralign Corporation Matériaux à base de collagène orientés, ses films et procédés de fabrication
US8067021B2 (en) * 2007-09-04 2011-11-29 Affinergy, Inc. Methods and compositions for delivery of growth factor to fibrous connective tissue
US8101116B2 (en) 2007-09-19 2012-01-24 Ethicon, Inc. Preformed support device and method and apparatus for manufacturing the same
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
AU2008311957A1 (en) 2007-10-15 2009-04-23 Wake Forest University Methods and compositions for printing biologically compatible nanotube composites of autologous tissue
US20090157193A1 (en) 2007-12-18 2009-06-18 Warsaw Orthopedic, Inc. Tendon and Ligament Repair Sheet and Methods of Use
WO2009099570A2 (fr) 2008-02-01 2009-08-13 Wake Forest University Health Sciences Système d’échafaudage aligné pour la régénération musculaire squelettique
US8048361B2 (en) 2008-05-20 2011-11-01 National Taiwan University Method for forming porous bio-mimicking scaffold
WO2009149181A2 (fr) 2008-06-06 2009-12-10 Organogenesis, Inc. Procédés et compositions pour manipuler des propriétés de matériau support électro-traité à l'aide d’une réticulation et d’une structure tertiaire fibreuse
US9387280B2 (en) 2008-09-05 2016-07-12 Synovis Orthopedic And Woundcare, Inc. Device for soft tissue repair or replacement
US9040665B2 (en) 2008-09-30 2015-05-26 Case Western Reserve University Controlled cross-linking processing of proteins
GB2466073A (en) * 2008-12-12 2010-06-16 Univ Manchester Tissue repair scaffold
WO2010081029A1 (fr) 2009-01-08 2010-07-15 Rotation Medical, Inc. Systèmes implantables de protection des tendons et trousses et procédés associés
US9597430B2 (en) 2009-07-31 2017-03-21 Synthasome, Inc. Synthetic structure for soft tissue repair
WO2011064773A1 (fr) 2009-11-24 2011-06-03 Collplant Ltd. Procédé de production de fibres de collagène
US9198750B2 (en) 2010-03-11 2015-12-01 Rotation Medical, Inc. Tendon repair implant and method of arthroscopic implantation
US9757132B2 (en) 2010-03-24 2017-09-12 Biorez, Inc. Mechanically competent scaffold for rotator cuff and tendon augmentation
EP2458043A1 (fr) 2010-11-24 2012-05-30 SpinPlant GmbH Produit de matériau réticulé et son procédé de fabrication
WO2012098419A1 (fr) 2011-01-20 2012-07-26 Centre National De La Recherche Scientifique Dispositif pour réparation tissulaire
EP2508212A1 (fr) 2011-04-05 2012-10-10 Universitätsklinikum Freiburg Système de couche de gradient biocompatible et biodégradable pour la médecine régénérative et pour le support de tissus
WO2013025819A2 (fr) 2011-08-16 2013-02-21 The University Of Kansas Timbre trachéal fibreux
CA2792081C (fr) 2011-10-11 2020-10-27 Bond University Ltd Compositions superposees comprenant une sangle de nanofibres 3d pour la regeneration des tissus
KR20130063769A (ko) 2011-12-07 2013-06-17 한국전자통신연구원 섬유 제조 방법 및 이에 의해 제조된 섬유
WO2013093921A1 (fr) 2011-12-20 2013-06-27 Collplant Ltd. Fibres de polymère synthétique enrobées de collagène
AU2013221580A1 (en) 2012-02-14 2014-08-28 Neograft Technologies, Inc. Kink resistant graft devices and related systems and methods
WO2013130586A1 (fr) 2012-02-27 2013-09-06 The Penn State Research Foundation Procédés et compositions se rapportant à des fibres d'amidon
CN104487103A (zh) 2012-05-15 2015-04-01 泰克尼恩研究和发展基金有限公司 纤维增强水凝胶复合材料和形成纤维增强水凝胶复合材料的方法
US20140011416A1 (en) 2012-07-05 2014-01-09 Board Of Regents Of The University Of Nebraska Three Dimensionally and Randomly Oriented Fibrous Structures
US9402710B2 (en) 2012-07-16 2016-08-02 The Board Of Trustees For The Leland Stanford Junior University Macroporous 3-D scaffolds for tissue engineering
US9757495B2 (en) 2013-02-01 2017-09-12 Children's Medical Center Corporation Collagen scaffolds
KR101494160B1 (ko) 2013-04-29 2015-02-17 한국생산기술연구원 은 나노 섬유 제조용 전기방사 용액 조성물
US9697044B2 (en) 2013-05-21 2017-07-04 Nvidia Corporation Application programming interface to enable the construction of pipeline parallel programs
US11046930B2 (en) 2013-06-13 2021-06-29 Aspect Biosystems Ltd. System for additive manufacturing of three-dimensional structures and method for same
ES2649616T3 (es) * 2013-06-17 2018-01-15 Hans U. Baer Matriz e implante para ingeniería de tejidos
AU2014315199B2 (en) * 2013-09-05 2018-04-19 The Penn State Research Foundation Bioelastomers and applications thereof
CN105530895B (zh) * 2013-09-13 2019-01-11 雅培心血管系统有限公司 编制支撑架
WO2015048224A1 (fr) 2013-09-25 2015-04-02 Johnson Jed K Échafaudages de fibres destinés à être utilisés pour créer des structures implantables
WO2015073925A2 (fr) 2013-11-15 2015-05-21 Neograft Technologies, Inc. Dispositifs de greffe, systèmes et procédés associés
EP3072536B1 (fr) * 2013-11-19 2020-06-03 Shanghai P & P Biotech Co., Ltd Matériau d'endoprothèse composite biologique à filage électrostatique hydrophile, utilisé pour une régénération de tissus, et son procédé de préparation et son application
EP3076948B1 (fr) 2013-12-06 2020-11-18 Allergan, Inc. Implant intra-camérulaire pour le traitement d'une pathologie oculaire
EP3089767A1 (fr) 2013-12-31 2016-11-09 3M Innovative Properties Company Échafaudages nanofibreux synthétiques composites et ses articles
EP3116557B1 (fr) 2014-03-14 2020-03-11 Scripps Health Électrofilage de matrices polymères pour cartilage et ménisque
US20160015852A1 (en) * 2014-07-15 2016-01-21 Industrial Technology Research Institute Composite material
WO2016042211A1 (fr) 2014-09-17 2016-03-24 University Of Helsinki Matériaux implantables et leur utilisation
WO2016149194A1 (fr) 2015-03-13 2016-09-22 MAM Holdings of West Florida, L.L.C. Compositions de collagène et utilisations d'implants de biomatériaux
KR102949849B1 (ko) 2015-04-03 2026-04-07 이샤이 아타르 가교된 단백질 폼의 생성을 위한 분말 조성물 및 그 이용 방법
WO2017053757A1 (fr) 2015-09-23 2017-03-30 The University Of Akron Procédés de rouleau à rouleau pour la fabrication de produits adhésifs secs
US11525042B2 (en) 2016-02-15 2022-12-13 Modern Meadow, Inc. Composite biofabricated material
EP3432940B1 (fr) 2016-03-25 2025-11-05 Biorez, Inc. Échafaudages tressés complexes pour une régénération tissulaire améliorée
US10305350B2 (en) 2016-11-18 2019-05-28 Cummins Power Generation Limited Generator set integrated gearbox
US10716876B2 (en) 2017-01-12 2020-07-21 Collplant Ltd. Method of generating collagen fibers
EP3609440B1 (fr) 2017-04-14 2025-01-22 Shoulder Innovations, Inc. Prothèse totale d'épaule comportant un implant glénoïdien intégré pouvant passer d'une configuration anatomique à une configuration inverse
EP3624730A4 (fr) 2017-05-16 2021-04-14 Embody Inc. Compositions de biopolymères, échafaudages et dispositifs
CN107261210B (zh) * 2017-07-24 2020-01-14 武汉理工大学 一种聚乳酸/β-磷酸钙/I型胶原复合神经导管及其制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010040129A2 (fr) * 2008-10-03 2010-04-08 Trustees Of Tufts College Echafaudages pour ingénierie tissulaire et médecine régénératrice
WO2014160019A1 (fr) * 2013-03-14 2014-10-02 Lifenet Health Fibre alignée et son procédé d'utilisation
WO2019084209A1 (fr) * 2017-10-24 2019-05-02 Embody Llc Implants d'échafaudage de biopolymère et leurs méthodes de production

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ALBERTO SENSINI ET AL: "Biofabrication of bundles of poly(lactic acid)-collagen blends mimicking the fascicles of the human Achille tendon", BIOFABRICATION, vol. 9, no. 1, 8 March 2017 (2017-03-08), pages 015025, XP055446261, DOI: 10.1088/1758-5090/aa6204 *
EUNICE P S TAN ET AL: "Effects of annealing on the structural and mechanical properties of electrospun polymeric nanofibres", NANOTECHNOLOGY, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL, GB, vol. 17, no. 10, 28 May 2006 (2006-05-28), pages 2649 - 2654, XP020103738, ISSN: 0957-4484, DOI: 10.1088/0957-4484/17/10/034 *
FULL SEAN MICHAEL ET AL: "Effect of fiber orientation of collagen-based electrospun meshes on human fibroblasts for ligament tissue engineering applications : Effect of Fiber Orientation of Collagen-Based Electrospun Meshes", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B: APPLIED BIOMATERIALS, vol. 103, no. 1, 23 April 2014 (2014-04-23), US, pages 39 - 46, XP055776693, ISSN: 1552-4973, DOI: 10.1002/jbm.b.33153 *
XIANGCHEN QIAO ET AL: "Compositional and in Vitro Evaluation of Nonwoven Type I Collagen/Poly-dl-lactic Acid Scaffolds for Bone Regeneration", JOURNAL OF FUNCTIONAL BIOMATERIALS, vol. 6, no. 3, 5 August 2015 (2015-08-05), pages 667 - 686, XP055576088, DOI: 10.3390/jfb6030667 *
XU YUAN ET AL: "Fabrication of Electrospun Poly(L-Lactide-co-[epsilon]-Caprolactone)/Collagen Nanoyarn Network as a Novel, Three-Dimensional, Macroporous, Aligned Scaffold for Tendon Tissue Engineering", TISSUE ENGINEERING. PART C, METHODS DEC 2008, vol. 19, no. 12, 1 December 2013 (2013-12-01), US, pages 925 - 936, XP055776516, ISSN: 1937-3384, DOI: 10.1089/ten.tec.2012.0328 *

Also Published As

Publication number Publication date
WO2018212792A3 (fr) 2019-01-17
US20190054205A1 (en) 2019-02-21
JP2020520389A (ja) 2020-07-09
US10835639B1 (en) 2020-11-17
US20250281666A1 (en) 2025-09-11
JP2025120178A (ja) 2025-08-15
AU2018268713B2 (en) 2024-04-18
US10617787B2 (en) 2020-04-14
CA3063847A1 (fr) 2018-11-22
US20200345891A1 (en) 2020-11-05
JP2023107869A (ja) 2023-08-03
AU2018268713A1 (en) 2019-12-12
US11116870B2 (en) 2021-09-14
US20220387666A1 (en) 2022-12-08
US20210379242A1 (en) 2021-12-09
EP3624730A2 (fr) 2020-03-25
US11331410B2 (en) 2022-05-17
WO2018212792A2 (fr) 2018-11-22
US12491287B2 (en) 2025-12-09
US20200338232A1 (en) 2020-10-29

Similar Documents

Publication Publication Date Title
DK3580561T3 (da) Hla-baserede metoder, sammensætninger og anvendelse heraf
PL3407888T3 (pl) Związki pirydopirolochinoksaliny, ich kompozycje i zastosowania
EP3497209A4 (fr) Compositions de poxvirus chimériques et leurs utilisations
EP3474820C0 (fr) Compositions glp-1 et ses utilisations
IL274297A (en) Pyrazolo-piperidine-converted indole-2-carboxamides, preparations containing them and their uses
DK3258939T3 (da) Neuroaktive steroider, sammensætninger og anvendelser heraf
EP3551238A4 (fr) Compositions désodorisantes, dispositifs de stomie et leurs utilisations
EP3607044C0 (fr) Compositions détergentes et leurs utilisations
DK3676297T3 (da) Forbindelser, sammensætninger og fremgangsmåder
EP3528716A4 (fr) Systèmes, dispositifs et procédés d'ostéotomie
DK3705488T3 (da) Neuroaktive steroider, sammensætninger og anvendelse heraf
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
EP3478308A4 (fr) Composition à base de cannabis et procédés
DK3655038T3 (da) Farmaceutisk sammensætning
DK3494119T3 (da) Forbindelser og sammensætninger og anvendelser deraf
LT3399978T (lt) Antiproliferaciniai junginiai, jų farmacinės kompozicijos ir naudojimas
PL3703518T3 (pl) Formulacja ulegająca aerozolowaniu
EP3568568A4 (fr) Réseaux de fractures discrètes à proximité d'un puits de forage
EP3258948C0 (fr) Compositions anti-inflammatoires et immunomodulatoires comprenant klebsormidium et utilisations de celles-ci
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
EP3638136C0 (fr) Dispositifs laparoscopiques
DK4234656T3 (da) Sammensætninger
DK3592430T3 (da) Antimikrobielle forbindelser, sammensætninger og anvendelser heraf
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
EP3478663A4 (fr) Polymère fonctionnalisé par un lactame, compositions et applications de celui-ci

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210312

RIC1 Information provided on ipc code assigned before grant

Ipc: A61F 2/08 20060101AFI20210308BHEP

Ipc: A61L 27/26 20060101ALI20210308BHEP

Ipc: A61L 15/32 20060101ALI20210308BHEP

Ipc: A61L 27/24 20060101ALI20210308BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20220321